Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 29 clinical trials
Methylphenidate in Childhood Apraxia of Speech

The purpose of this study is to describe the possible effects of methylphenidate (MPH) on speech intelligibility in children with childhood apraxia of speech (CAS) aged 6-12 years. This outcome

  • 0 views
  • 14 May, 2022
  • 1 location
TAME-PD - Physical Therapy, Atomoxetine and, Methylphenidate, to Enhance Gait and Balance in Parkinson's Disease (TAME-PD)

above have not been explored yet. The investigators want to evaluate whether the addition of medication, either low dose of methylphenidate or atomoxetine, to physical therapy will achieve improvement

medication regimen
  • 18 views
  • 23 Mar, 2022
  • 1 location
Differences by Sex and Genotype in the Effects of Stress on Executive Functions

on the frontal lobe. The investigators would also like to investigate how gender differences and genotype mediate the effect of methylphenidate (MPH) on EFs.

Accepts healthy volunteers
  • 23 views
  • 29 May, 2022
  • 1 location
Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder (AMPAIII)

Attention-Deficit/Hyperactivity Disorder (ADHD) is the most commonly diagnosed neurobehavioral disorder in childhood. Children with ADHD struggle in school due to problems with attention and high levels of impulsivity and hyperactivity. They are at substantially increased risk for long-term difficulties into adulthood, including academic underachievement, substance abuse, and criminal behavior. The …

Accepts healthy volunteers
  • 0 views
  • 27 Jun, 2022
  • 2 locations
Effects of Genotype on Resting State Connectivity During Methamphetamine Administration (MATAAR)

Addiction to methamphetamine (MA) is a serious health problem in the United States. Right now, there are no medically approved treatments for MA dependence. More research is needed to understand how MA affects the brain and to eventually develop medical interventions for MA addiction. The purpose of the study is …

Accepts healthy volunteers
  • 0 views
  • 12 Oct, 2022
  • 2 locations
Methylphenidate in Adults With Attention Deficit/Hyperactivity Disorder

Methylphenidate (MPH) is the first-line pharmacological treatment for adults with Attention-Deficit/Hyperactivity Disorder (ADHD). Nevertheless, there is considerable interindividual variability

attention deficit disorder
methylphenidate
psychiatric disorder
  • 661 views
  • 21 Jan, 2021
  • 2 locations
Methylphenidate for Ptsd and Stroke Veterans

trials. Methylphenidate (MPH) is a central nervous system stimulant that can improve PTSD symptoms: avoidance behaviors, social withdrawal, hyperarousal, and working memory. MPH can also improve post

antipsychotics
  • 0 views
  • 21 Mar, 2022
  • 1 location
Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD

The study team will determine the association between d,l-methylphenidate (MPH) therapeutic outcomes in ADHD patients and genetic variants of CES1 and reveal key associations between CES1

  • 46 views
  • 22 Apr, 2022
  • 2 locations
The Effects of a Single Dose of Methylphenidate on Motor Performance

Aim: To evaluate the effects of MPH on young adults diagnosed with ADHD on different exercise performance tests. Hypothesis: MPH will have positive effects on motor tests requiring concentration. Methods: 200 healthy physical education students, 100 participants diagnosed with ADHD will serve as the treatment group and 100 non-ADHD diagnosed …

Accepts healthy volunteers
  • 0 views
  • 08 Jul, 2022
  • 1 location
The Effect of Methylphenidate Treatment in Familial Attention Deficit/Hyperactivity Disorder (ADHD)

The purpose of this study is to investigate the familial response to Methylphenidate treatment (Ritalin IR) in two aspects: ADHD symptom's improvement and side-effects development.

  • 4 views
  • 25 May, 2022
  • 1 location